Azitra, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Azitra, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Shareholder Slice Ratio: Share count rose 17,655% in 3 years, so each share's slice of the company became smaller. Bigger rise in share count than 96% of Healthcare companies in United States.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
-32.6×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Lower than 66% of Healthcare companies in United States.
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
1/3 · 1/3Sales grew in 1 of the last 3 years; profit grew in 1 of 3.
Less steady than 70% of Healthcare companies in United States.
Growth Efficiency Ratio
—Sales fell 100%
Sales fell 100% in 3 years, so extra profit per extra sales cannot be measured.
Asset Productivity Ratio
-100% / -30%In 3 years sales changed by -100% while total assets changed by -30%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
-42.2×Operating cash was negative last year, while some debt falls due within a year.
Lower than 69% of Healthcare companies in United States.
Cash Cushion Ratio
+38%Cash, after subtracting all debt, equals 38% of its market value (net cash).
Higher than 73% of Healthcare companies in United States.
Tangible Assets Ratio
94%Of every $100 the company owns, $94 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 68% of Healthcare companies in United States.
Tangible Net Worth Ratio
92%Of every $100 of net worth, $92 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 74% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (11)
Azitra, Inc. made a loss over the last year. Azitra, Inc. owes $0.18 for every $1 it owns. Azitra, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossAzitra, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
0.59The share price is 0.59 times Azitra, Inc.'s book value per share, lower than 89% of Healthcare companies in United States.
Market cap
$4 MThe total market value of all of Azitra, Inc.'s shares at today's price (share price × number of shares), smaller than 94% of Healthcare companies in United States. PosiCap size class: Nano Cap.
Net worth (book value)
$7 MWhat Azitra, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$0.12Net worth divided by the number of shares. The share price of $0.07 is 0.6 times this, which is the P/B above.
Return on equity (ROE)
-256.7%Azitra, Inc. lost 256.7% of its shareholders' money over the last year, lower than 88% of Healthcare companies in United States.
Owes vs Owns
0.18×Azitra, Inc. owes $0.18 for every $1 it owns (low), lower than 76% of Healthcare companies in United States.
Dividend yield
NoneAzitra, Inc. does not currently pay a dividend.
Profit growth
LossAzitra, Inc. made a loss in each of the last two years.
Interest cover
Not coveredAzitra, Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.
Cash vs debt
Net cashAzitra, Inc. held $2 M more cash than debt (net cash) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Azitra, Inc.: $4 M ÷ $7 M (30 Jun 2026) = 0.6.
What is Azitra, Inc.'s return on equity?
Azitra, Inc. lost 256.7% of its shareholders' money over the last year, lower than 88% of Healthcare companies in United States.
How much does Azitra, Inc. owe compared with what it owns?
Azitra, Inc. owes $0.18 for every $1 it owns (low), lower than 76% of Healthcare companies in United States.
Does Azitra, Inc. pay a dividend?
No. Azitra, Inc. does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.